Conegliano Ventures

Conegliano Ventures is an Italian investment vehicle and venture capital firm that specializes in the life sciences and biotechnology sectors. The firm is best known for organizing club deals that aggregate capital from private investors to provide seed and early-stage funding to innovative biotech startups. It played a foundational role in the creation and financing of Genenta Science, a clinical-stage company developing gene therapies for cancer, and has also been a key investor in Altheia Science. Its investment focus is primarily on advanced therapeutic modalities, including gene and cell therapies for oncology and autoimmune disorders. By bridging the gap between private capital and high-potential scientific ventures, Conegliano Ventures plays a significant role in fostering the Italian biotechnology ecosystem.